ALDACTAZIDE از شرکت PFIZER

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ALDACTAZIDE از شرکت PFIZER

New Drug Application (NDA): 012616

Company: PFIZER

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALDACTAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25MG;25MG TABLET;ORAL Prescription

AB

Yes No
ALDACTAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 50MG;50MG TABLET;ORAL Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/27/1961 ORIG-1 Approval

Type 4 – New Combination

STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/19/2021 SUPPL-81 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012616s081lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/012616Orig1s081ltr.pdf

08/20/2020 SUPPL-80 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/012616s080lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/012616Orig1s080ltr.pdf

01/17/2019 SUPPL-78 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012616s078lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/012616Orig1s078ltr.pdf

10/22/2014 SUPPL-76 Labeling-Package Insert

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s076lbl.pdf

03/06/2014 SUPPL-75 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s075lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s075ltr.pdf

01/17/2014 SUPPL-74 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s074lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s074ltr.pdf

06/12/2013 SUPPL-73 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012616s073lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/012616Orig1s073ltr.pdf

06/14/2013 SUPPL-72 Manufacturing (CMC)

Label is not available on this site.

09/22/2011 SUPPL-69 Labeling-Package Insert

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s069ltr.pdf

05/19/2011 SUPPL-68 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012616s068lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s068ltr.pdf

11/26/2002 SUPPL-63 Manufacturing (CMC)-Control

Label is not available on this site.

04/21/1999 SUPPL-62 Labeling

Label is not available on this site.

01/13/1999 SUPPL-61 Labeling

Label is not available on this site.

11/13/1997 SUPPL-58 Labeling

Label is not available on this site.

01/23/1990 SUPPL-55 Manufacturing (CMC)

Label is not available on this site.

11/13/1997 SUPPL-37 Labeling

Label is not available on this site.

01/04/1978 SUPPL-16 Unspecified

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/19/2021 SUPPL-81

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012616s081lbl.pdf
08/20/2020 SUPPL-80

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/012616s080lbl.pdf
01/17/2019 SUPPL-78

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012616s078lbl.pdf
10/22/2014 SUPPL-76

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s076lbl.pdf
03/06/2014 SUPPL-75

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s075lbl.pdf
01/17/2014 SUPPL-74

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s074lbl.pdf
06/12/2013 SUPPL-73

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012616s073lbl.pdf
05/19/2011 SUPPL-68

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012616s068lbl.pdf

ALDACTAZIDE

TABLET;ORAL; 25MG;25MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ALDACTAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25MG;25MG TABLET;ORAL Prescription Yes AB 012616 PFIZER
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25MG;25MG TABLET;ORAL Prescription No AB 086513 MYLAN
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25MG;25MG TABLET;ORAL Prescription No AB 089534 SUN PHARM INDUSTRIES
بخوانید  CEFADYL از شرکت APOTHECON
به بالای صفحه بردن